JPM · NYSE
The supplied consensus is Buy across 24 analysts, with a mean target of $370; low and high targets are not provided. Other disclosed aggregations show a $351.81 average target from 24 analysts and a $375.08 12-month average target from TipRanks, while Evercore ISI Group cited the least bullish specific target at $340 on April 17, 2026. Thus, published targets cluster around the mid-$350s to mid-$370s, but the available spread runs from $340 to $375.08. No named analyst revision during the past week is supplied, so the direction of revisions cannot be established. The substantive disagreement is whether earnings momentum and financial-sector leadership outweigh valuation and macro-market caution.